157 related articles for article (PubMed ID: 24862967)
1. Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research.
Klanova M; Soukup T; Jaksa R; Molinsky J; Lateckova L; Maswabi BC; Prukova D; Brezinova J; Michalova K; Vockova P; Hernandez-Ilizaliturri F; Kulvait V; Zivny J; Vokurka M; Necas E; Trneny M; Klener P
Lab Invest; 2014 Jul; 94(7):806-17. PubMed ID: 24862967
[TBL] [Abstract][Full Text] [Related]
2. NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines.
Verner J; Trbusek M; Chovancova J; Jaskova Z; Moulis M; Folber F; Halouzka R; Mayer J; Pospisilova S; Doubek M
Leuk Lymphoma; 2015; 56(11):3198-206. PubMed ID: 25827173
[TBL] [Abstract][Full Text] [Related]
3. In vivo growth of mantle cell lymphoma xenografts in immunodeficient mice is positively regulated by VEGF and associated with significant up-regulation of CD31/PECAM1.
Molinský J; Klánová M; Maswabi B; Soukup T; Trněný M; Nečas E; Živný J; Klener P
Folia Biol (Praha); 2013; 59(1):26-31. PubMed ID: 23537525
[TBL] [Abstract][Full Text] [Related]
4. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.
Pearson T; Shultz LD; Miller D; King M; Laning J; Fodor W; Cuthbert A; Burzenski L; Gott B; Lyons B; Foreman O; Rossini AA; Greiner DL
Clin Exp Immunol; 2008 Nov; 154(2):270-84. PubMed ID: 18785974
[TBL] [Abstract][Full Text] [Related]
5. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
6. A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
Wang M; Zhang L; Han X; Yang J; Qian J; Hong S; Lin P; Shi Y; Romaguera J; Kwak LW; Yi Q
Clin Cancer Res; 2008 Apr; 14(7):2154-60. PubMed ID: 18381957
[TBL] [Abstract][Full Text] [Related]
7. Development of a murine model for blastoid variant mantle-cell lymphoma.
Ford RJ; Shen L; Lin-Lee YC; Pham LV; Multani A; Zhou HJ; Tamayo AT; Zhang C; Hawthorn L; Cowell JK; Ambrus JL
Blood; 2007 Jun; 109(11):4899-906. PubMed ID: 17311992
[TBL] [Abstract][Full Text] [Related]
8. Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy.
Silkenstedt E; Arenas F; Colom-Sanmartí B; Xargay-Torrent S; Higashi M; Giró A; Rodriguez V; Fuentes P; Aulitzky WE; van der Kuip H; Beà S; Toribio ML; Campo E; López-Guerra M; Colomer D
J Exp Clin Cancer Res; 2019 Nov; 38(1):446. PubMed ID: 31676012
[TBL] [Abstract][Full Text] [Related]
9. p110α Inhibition Overcomes Stromal Cell-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma.
Guan J; Huang D; Yakimchuk K; Okret S
Mol Cancer Ther; 2018 May; 17(5):1090-1100. PubMed ID: 29483220
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based therapy for mantle cell lymphoma.
Munger CM; Vose JM; Joshi SS
Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma.
Baiocchi RA; Alinari L; Lustberg ME; Lin TS; Porcu P; Li X; Johnston JS; Byrd JC; Blum KA
Cancer; 2011 Jun; 117(11):2442-51. PubMed ID: 24048792
[TBL] [Abstract][Full Text] [Related]
14. Cobblestone-area forming cells derived from patients with mantle cell lymphoma are enriched for CD133+ tumor-initiating cells.
Medina DJ; Abass-Shereef J; Walton K; Goodell L; Aviv H; Strair RK; Budak-Alpdogan T
PLoS One; 2014; 9(4):e91042. PubMed ID: 24722054
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
16. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal
Prukova D; Andera L; Nahacka Z; Karolova J; Svaton M; Klanova M; Havranek O; Soukup J; Svobodova K; Zemanova Z; Tuskova D; Pokorna E; Helman K; Forsterova K; Pacheco-Blanco M; Vockova P; Berkova A; Fronkova E; Trneny M; Klener P
Clin Cancer Res; 2019 Jul; 25(14):4455-4465. PubMed ID: 31004002
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of therapy-resistant mantle cell lymphoma cell lines derived from different tissue sites.
Ahrens AK; Chaturvedi NK; Nordgren TM; Dave BJ; Joshi SS
Leuk Lymphoma; 2012 Nov; 53(11):2269-78. PubMed ID: 22568512
[TBL] [Abstract][Full Text] [Related]
19. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
